MBL2 and cutaneous mastocytosis: Previous case reports described a case of CM 19 months after cladribine therapy in a patient with HCL (7) and chronic relapsing CM in a patient with low mannose-binding lectin and a low naïve CD4 cell count (8), both exhibiting similarities with the present case.